GO:0035691 macrophage migration inhibitory factor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035691 describes the signaling cascade triggered when macrophage migration inhibitory factor (MIF) binds its receptor on a target cell, leading to downstream transcriptional and cellular responses.
• MIF signals through multiple receptors, most notably CD74 (with CD44), and also ACKR3/CXCR4/CXCR7, activating MAPK, NF-kB, and PI3K-AKT pathways.
• MIF signaling is causally implicated in cancer progression, metastasis, fibrosis, arrhythmogenesis, intervertebral disc degeneration, and cancer cachexia.
• MIF-CD74 signaling drives fibrogenic macrophage recruitment in pulmonary fibrosis and promotes pre-metastatic niche formation in pancreatic cancer.
• Pharmacological or genetic inhibition of MIF signaling (e.g., CPSI-1306, anti-MIF antibodies) attenuates disease phenotypes in mouse models, validating the pathway as a therapeutic target.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect the causal roles of MIF pathway components in disease.
Description
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine originally identified for its ability to inhibit random migration of macrophages. The Gene Ontology term GO:0035691, macrophage migration inhibitory factor signaling pathway, captures the series of molecular signals initiated by MIF binding to its receptor on the surface of a target cell and ending with regulation of a downstream cellular process, such as transcription. This pathway is now recognized as a central node in inflammation, immune regulation, and tissue remodeling, with dysregulation linked to cancer, fibrosis, and metabolic disorders. Understanding MIF signaling is critical because it operates through non-canonical receptor complexes, including CD74/CD44, ACKR3, CXCR4, and CXCR7, and activates diverse intracellular cascades such as MAPK, NF-kB, and PI3K-AKT. These features make it a high-value target for both mechanistic studies and therapeutic intervention. Recent work has demonstrated that MIF signaling drives pre-metastatic niche formation in pancreatic cancer, promotes fibrogenic macrophage migration in lung fibrosis, and contributes to cancer cachexia through ACKR3. For researchers, GO:0035691 provides a structured framework to annotate and interrogate MIF-dependent processes. This article synthesizes authoritative QuickGO data and verified PubMed literature to outline the mechanism, key genes, disease relevance, and experimental strategies for studying MIF signaling.
macrophage migration inhibitory factor signaling pathway At A Glance
| GO ID | GO:0035691 |
|---|---|
| GO term | macrophage migration inhibitory factor signaling pathway |
| Ontology | biological_process |
| Synonym | MIF signaling pathway; macrophage migration inhibitory factor signalling pathway |
| Definition | The series of molecular signals initiated by macrophage migration inhibitory factor binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| Major function | Transduces MIF-initiated signals to regulate transcription, inflammation, cell survival, and migration. |
| Key receptors | CD74 (with CD44), ACKR3, CXCR4, CXCR7. |
| Major downstream pathways | MAPK, NF-kB, PI3K-AKT. |
What Is GO:0035691?
GO:0035691, macrophage migration inhibitory factor signaling pathway, is defined as the series of molecular signals initiated by macrophage migration inhibitory factor binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. It is a biological process ontology term with synonyms including macrophage migration inhibitory factor signalling pathway and MIF signaling pathway.
Why Is macrophage migration inhibitory factor signaling pathway Important in Cell Biology?
MIF signaling is a critical regulator of innate and adaptive immunity, and its dysregulation is causally linked to a broad spectrum of human diseases, including cancer, fibrosis, cardiovascular disorders, and degenerative conditions. Because MIF signals through multiple receptor complexes and activates diverse downstream cascades, it represents both a mechanistic hub and a promising therapeutic target. Understanding GO:0035691 is therefore essential for researchers aiming to develop targeted interventions.
• MIF signaling drives fibrogenic macrophage recruitment in pulmonary fibrosis.
• MIF-CD74 signaling increases atrial arrhythmogenesis.
• MIF promotes intervertebral disc degeneration via NF-kB.
• MIF-ACKR3 causes irreversible fat loss in cancer cachexia.
• MIF signaling is involved in oncovirus infection and virus-associated cancers.
• Pancreatic cancer exosomes initiate pre-metastatic niche formation via MIF.
• MIF signaling promotes M2 macrophage polarization in colorectal cancer liver metastasis.
• Inhibition of MIF attenuates bleomycin-induced pulmonary fibrosis via MAPK.
• MIF is a therapeutic target in inflammatory and fibrotic diseases.
• CRISPR models enable causal dissection of MIF pathway components.
What Happens During macrophage migration inhibitory factor signaling pathway?
MIF Secretion and Receptor Binding
In simple terms: MIF is released from cells and binds to receptors on target cells to start signaling.
MIF is secreted by various cell types, including macrophages and epithelial cells, and binds to cell surface receptors such as CD74, ACKR3, CXCR4, and CXCR7. In pulmonary fibrosis, dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor-CD74 signaling. MIF binding to CD74 initiates the signaling cascade.
Receptor Complex Formation and Activation
In simple terms: MIF binding causes receptors to cluster and activate intracellular signaling.
CD74 forms a complex with CD44 to transduce MIF signals. MIF also signals through ACKR3, which is a non-canonical chemokine receptor. In atrial arrhythmogenesis, MIF increases signaling through CD74. The receptor complex activates downstream kinases and transcription factors.
Downstream Kinase Cascades
In simple terms: Activated receptors turn on kinase pathways like MAPK and PI3K-AKT.
MIF signaling activates the MAPK pathway, as shown in bleomycin-induced pulmonary fibrosis where inhibition of MIF attenuates fibrosis via MAPK. MIF also activates NF-kB, contributing to intervertebral disc degeneration. In cancer cachexia, MIF-ACKR3 impairs adipogenesis through downstream signaling.
Transcriptional Regulation and Cellular Responses
In simple terms: Signals reach the nucleus and change gene expression, leading to cellular changes.
MIF signaling culminates in regulation of transcription, e.g., NF-kB-driven gene expression in intervertebral disc degeneration. In colorectal cancer, MIF signaling drives M2 macrophage polarization to promote liver metastasis. In pancreatic cancer, exosomal MIF initiates pre-metastatic niche formation in the liver.
Key Genes Involved in GO:0035691 macrophage migration inhibitory factor signaling pathway
The following genes and proteins are central to the macrophage migration inhibitory factor signaling pathway (GO:0035691).
| Gene | Major Role | Research Relevance |
|---|---|---|
| MIF | Ligand that initiates signaling | Central to pathway; target for inhibition |
| CD74 | MIF receptor; forms complex with CD44 | Mediates MIF signaling in fibrosis and arrhythmogenesis |
| CD44 | Co-receptor for CD74 | Required for MIF-CD74 signaling |
| ACKR3 | MIF receptor; atypical chemokine receptor | Mediates fat loss in cancer cachexia |
| CXCR4 | MIF receptor | Contributes to MIF signaling |
| CXCR7 | MIF receptor | Contributes to MIF signaling |
| MAPK1 | Downstream kinase in MAPK pathway | Mediates MIF-induced fibrosis |
| MAPK3 | Downstream kinase in MAPK pathway | Mediates MIF-induced fibrosis |
| NFKB1 | Transcription factor downstream of MIF | Drives intervertebral disc degeneration |
| RELA | NF-kB subunit | Mediates MIF-induced transcription |
| PIK3CA | PI3K subunit | Potential downstream effector |
| AKT1 | Serine/threonine kinase | Potential downstream effector |
| ENO2 | Enolase 2; drives M2 polarization | Promotes colorectal cancer liver metastasis via MIF |
| STAT3 | Transcription factor | Potential mediator of MIF signaling |
| CCL2 | Chemokine | Recruits macrophages in MIF-driven fibrosis |
| TGFB1 | Fibrogenic cytokine | Cooperates with MIF in fibrosis |
| IL6 | Inflammatory cytokine | Induced by MIF signaling |
| TNF | Inflammatory cytokine | Induced by MIF signaling |
How Is macrophage migration inhibitory factor signaling pathway Regulated?
MIF signaling is regulated at multiple levels. Receptor availability and complex formation with CD44 modulate signal strength. Downstream, MAPK and NF-kB pathways are subject to feedback regulation. In cancer cachexia, MIF-ACKR3 signaling impairs adipogenesis, and this process is regulated by the metabolic state. Pharmacological inhibitors such as CPSI-1306 can block MIF activity and alleviate disease phenotypes.
macrophage migration inhibitory factor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MIF | Pulmonary fibrosis | Bleomycin-induced mouse model; MIF KO mice |
| CD74 | Atrial arrhythmogenesis | CD74 KO mice; cardiac-specific overexpression |
| ACKR3 | Cancer cachexia | ACKR3 KO mice; adipocyte-specific models |
| MIF | Intervertebral disc degeneration | MIF KO mice; CPSI-1306 treatment |
| ENO2 | Colorectal cancer liver metastasis | ENO2 KO cancer cells; MIF signaling inhibition |
MIF Signaling in Cancer
MIF signaling is implicated in oncovirus infection and virus-associated cancers. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver via MIF. In colorectal cancer, ENO2 drives tumor cell-induced M2 macrophage polarization to promote liver metastasis, a process linked to MIF signaling. These findings highlight MIF as a therapeutic target in oncology.
MIF Signaling in Fibrosis
Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage MIF-CD74 signaling in pulmonary fibrosis. Inhibition of MIF attenuates bleomycin-induced murine pulmonary fibrosis via the MAPK pathway. These studies demonstrate a causal role for MIF signaling in fibrotic remodeling.
MIF Signaling in Cardiovascular and Musculoskeletal Disorders
MIF increases atrial arrhythmogenesis through CD74 signaling. MIF promotes intervertebral disc degeneration through the NF-kB pathway, and the MIF inhibitor CPSI-1306 alleviates degeneration in a mouse model. These findings link MIF signaling to cardiovascular and musculoskeletal pathologies.
MIF Signaling in Metabolic Disorders
MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia. This identifies MIF signaling as a driver of metabolic wasting in cancer patients.
From macrophage migration inhibitory factor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MIF drive fibrosis? | MIF knockout mouse; bleomycin-induced fibrosis |
| Does CD74 mediate arrhythmogenesis? | CD74 knockout mouse; cardiac electrophysiology |
| Does ACKR3 mediate fat loss? | ACKR3 knockout mouse; cancer cachexia model |
| Does MIF promote disc degeneration? | MIF knockout mouse; CPSI-1306 treatment |
| Does ENO2 regulate M2 polarization? | ENO2 knockout cancer cells; co-culture with macrophages |
| Does MIF initiate pre-metastatic niche? | Exosome transfer; MIF knockout pancreatic cancer cells |
How to Study the macrophage migration inhibitory factor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Test causal role of MIF pathway genes |
| RNA-seq | Transcriptional changes | Identify downstream targets of MIF signaling |
| Proteomics | Protein expression and modifications | Map signaling networks |
| Flow cytometry | Immune cell phenotype | Assess M2 polarization |
| Western blot | Protein phosphorylation | Measure MAPK/NF-kB activation |
| ELISA | Cytokine secretion | Quantify MIF, IL-6, TNF |
| Immunohistochemistry | Tissue protein localization | Detect MIF in fibrotic tissue |
| Exosome isolation | Vesicle cargo | Study pre-metastatic niche |
Genetic Knockout Models
CRISPR-Cas9 knockout of MIF, CD74, ACKR3, or ENO2 in mice or cell lines enables causal testing of their roles in MIF signaling. For example, MIF knockout attenuates bleomycin-induced fibrosis.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can identify downstream transcriptional and signaling changes upon MIF stimulation or inhibition. These approaches reveal pathway crosstalk and biomarkers.
Pharmacological Inhibition
Small molecule inhibitors such as CPSI-1306 or anti-MIF antibodies can block MIF signaling in vivo and in vitro. These tools complement genetic models.
Imaging and Flow Cytometry
Flow cytometry can assess macrophage polarization and immune cell recruitment in MIF-driven diseases. Imaging can track pre-metastatic niche formation.
How CRISPR Can Be Used to Study GO:0035691 macrophage migration inhibitory factor signaling pathway
Knockout
CRISPR knockout of MIF, CD74, ACKR3, or downstream effectors is used to abrogate MIF signaling and test its requirement in disease models. For example, MIF knockout mice show reduced fibrosis.
Point Mutation
Point mutations can be introduced to disrupt specific MIF-receptor interactions or kinase activities, allowing fine mapping of signaling nodes. This is useful for dissecting phospho-dependent events.
Knock-in
Knock-in of tagged or reporter alleles (e.g., GFP-MIF) enables tracking of MIF expression and secretion in vivo. Knock-in of human MIF into mouse models can facilitate translational studies.
Overexpression
Overexpression of MIF or its receptors via CRISPR activation or lentiviral delivery can drive pathway activation and model disease phenotypes. This is valuable for gain-of-function studies.
How EDITGENE Supports macrophage migration inhibitory factor signaling pathway Research
Researchers studying macrophage migration inhibitory factor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in disease initiation, progression, or treatment response. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional validation of MIF pathway components.
Contact EDITGENE today to design your custom CRISPR model for macrophage migration inhibitory factor signaling pathway research.
Frequently Asked Questions About macrophage migration inhibitory factor signaling pathway
What is the macrophage migration inhibitory factor signaling pathway?
It is the series of molecular signals initiated by MIF binding to its receptor on a target cell, leading to regulation of downstream cellular processes such as transcription (GO:0035691).
What genes are involved in MIF signaling?
Key genes include MIF, CD74, CD44, ACKR3, CXCR4, CXCR7, MAPK1, MAPK3, NFKB1, RELA, and ENO2.
What receptors does MIF bind?
MIF binds CD74 (with CD44), ACKR3, CXCR4, and CXCR7.
What diseases are associated with MIF signaling?
MIF signaling is linked to cancer, pulmonary fibrosis, atrial arrhythmogenesis, intervertebral disc degeneration, and cancer cachexia.
How is MIF signaling regulated?
It is regulated by receptor availability, complex formation with CD44, and feedback on MAPK and NF-kB pathways.
What are the downstream pathways of MIF signaling?
Major downstream pathways include MAPK, NF-kB, and PI3K-AKT.
Can MIF signaling be inhibited therapeutically?
Yes, inhibitors such as CPSI-1306 and anti-MIF antibodies attenuate disease in preclinical models.
What model systems are used to study MIF signaling?
Knockout mice, cell lines, and exosome transfer models are commonly used.
What is the role of MIF in cancer?
MIF promotes pre-metastatic niche formation, M2 macrophage polarization, and metastasis in several cancers.
How can CRISPR help study MIF signaling?
CRISPR knockout, knock-in, and overexpression models enable causal dissection of MIF pathway components in disease.
Conclusion
The macrophage migration inhibitory factor signaling pathway (GO:0035691) is a central mediator of inflammation, immune regulation, and tissue remodeling, with causal roles in cancer, fibrosis, cardiovascular disease, and metabolic disorders. Its complex receptor architecture and diverse downstream cascades make it a rich area for mechanistic and therapeutic research. By leveraging CRISPR-based models and multi-omics approaches, researchers can precisely dissect the contribution of each pathway component. EDITGENE provides the tools and expertise to accelerate these discoveries.
References
- 1. Kim SH et al.. 2025. Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor-CD74 signaling.. Sci Transl Med 17(827):eadr2277 PMID: 41337540
- 2. Fan J et al.. 2025. Roles of Macrophage Migration Inhibitory Factor (MIF) Signaling Pathway in Oncovirus Infection and Virus-Associated Cancers.. Viruses 17(12) PMID: 41472252
- 3. Costa-Silva B et al.. 2015. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.. Nat Cell Biol 17(6):816-26 PMID: 25985394
- 4. Cui Q et al.. 2025. MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia.. Cell Metab 37(4):954-970.e8 PMID: 40020680
- 5. Cheng WL et al.. 2020. Macrophage migration inhibitory factor increases atrial arrhythmogenesis through CD74 signaling.. Transl Res 216:43-56 PMID: 31669150
- 6. Tang J et al.. 2026. ENO2 drives tumor cell-induced M2 macrophage polarization to promote colorectal cancer liver metastasis.. Signal Transduct Target Ther 11(1) PMID: 42082451
- 7. Wang J et al.. 2026. Inhibition of macrophage migration inhibitory factor attenuates bleomycin-induced murine pulmonary fibrosis via the MAPK pathway.. Respir Res 27(1) PMID: 42143357
- 8. Zhang Y et al.. 2023. Macrophage migration inhibitory factor (MIF) promotes intervertebral disc degeneration through the NF-κB pathway, and the MIF inhibitor CPSI-1306 alleviates intervertebral disc degeneration in a mouse model.. FASEB J 37(12):e23303 PMID: 37983963
